Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve 1. To consider the appointment ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asston Pharmaceuticals has called a board meeting on 30 March 2026 at 3:00 PM. Key items on the agenda include the appointment of Mr. Sumit Pawar as Chief Financial Officer, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director. The board will also take note of a circular resolution already passed for the appointment of a statutory auditor. Additionally, it will consider approving the date and notice for an Extraordinary General Meeting (EGM) of the company.
The agenda suggests significant board-level restructuring, with multiple new appointments including a CFO and two new directors, which may indicate strengthening of governance or filling of recent vacancies. The upcoming EGM hints at further shareholder-level decisions, so investors should watch for the outcomes announced after 30 March 2026.